Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dermatitis, Allergic Contact | 4 | 2022 | 12 | 1.520 |
Why?
|
| Hemangioma, Capillary | 2 | 2022 | 6 | 1.040 |
Why?
|
| Dermatitis, Atopic | 2 | 2021 | 17 | 0.940 |
Why?
|
| Skin Neoplasms | 4 | 2021 | 375 | 0.890 |
Why?
|
| Candidiasis | 1 | 2023 | 39 | 0.860 |
Why?
|
| Fetal Diseases | 1 | 2023 | 64 | 0.840 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2022 | 7 | 0.840 |
Why?
|
| Alopecia Areata | 1 | 2022 | 17 | 0.840 |
Why?
|
| Scleroderma, Localized | 1 | 2022 | 19 | 0.830 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2023 | 91 | 0.810 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2022 | 6 | 0.810 |
Why?
|
| Hemangioma | 1 | 2022 | 51 | 0.810 |
Why?
|
| Arthritis | 1 | 2022 | 53 | 0.810 |
Why?
|
| Cantharidin | 1 | 2021 | 5 | 0.760 |
Why?
|
| Molluscum Contagiosum | 1 | 2021 | 3 | 0.760 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2021 | 7 | 0.760 |
Why?
|
| Premature Birth | 1 | 2023 | 150 | 0.750 |
Why?
|
| Sleep Wake Disorders | 1 | 2021 | 94 | 0.690 |
Why?
|
| Nevus, Pigmented | 1 | 2019 | 30 | 0.650 |
Why?
|
| Allergens | 3 | 2022 | 54 | 0.620 |
Why?
|
| Detergents | 1 | 2017 | 34 | 0.580 |
Why?
|
| Infant | 7 | 2023 | 2891 | 0.580 |
Why?
|
| Skin | 2 | 2022 | 451 | 0.570 |
Why?
|
| Thiazoles | 1 | 2017 | 95 | 0.560 |
Why?
|
| Numismatics | 1 | 2015 | 5 | 0.530 |
Why?
|
| Child | 9 | 2022 | 6405 | 0.520 |
Why?
|
| Metals | 1 | 2015 | 100 | 0.500 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 756 | 0.480 |
Why?
|
| Lyme Disease | 1 | 2014 | 17 | 0.470 |
Why?
|
| Exanthema | 1 | 2014 | 30 | 0.470 |
Why?
|
| Glucocorticoids | 3 | 2019 | 222 | 0.390 |
Why?
|
| Humans | 19 | 2023 | 68618 | 0.390 |
Why?
|
| Patch Tests | 4 | 2022 | 5 | 0.380 |
Why?
|
| Neurotic Disorders | 1 | 2009 | 13 | 0.330 |
Why?
|
| Neuropeptide Y | 1 | 2009 | 11 | 0.330 |
Why?
|
| Triamcinolone | 2 | 2019 | 11 | 0.320 |
Why?
|
| Infant, Newborn | 2 | 2023 | 2455 | 0.270 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 1140 | 0.240 |
Why?
|
| Lasers, Dye | 2 | 2021 | 4 | 0.230 |
Why?
|
| Skin Pigmentation | 1 | 2022 | 25 | 0.210 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2023 | 69 | 0.210 |
Why?
|
| Retrospective Studies | 4 | 2022 | 7277 | 0.210 |
Why?
|
| Alopecia | 1 | 2022 | 45 | 0.200 |
Why?
|
| Female | 7 | 2023 | 38074 | 0.200 |
Why?
|
| Skin Ulcer | 1 | 2021 | 19 | 0.190 |
Why?
|
| Pyrimidines | 1 | 2022 | 178 | 0.190 |
Why?
|
| Port-Wine Stain | 1 | 2020 | 7 | 0.190 |
Why?
|
| Infant, Premature | 1 | 2023 | 284 | 0.190 |
Why?
|
| Laser Therapy | 1 | 2020 | 54 | 0.180 |
Why?
|
| Antibodies, Antinuclear | 1 | 2021 | 171 | 0.180 |
Why?
|
| Epidermolysis Bullosa Simplex | 1 | 2019 | 1 | 0.170 |
Why?
|
| Keratin-5 | 1 | 2019 | 1 | 0.170 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2019 | 6 | 0.170 |
Why?
|
| Mothers | 1 | 2021 | 172 | 0.170 |
Why?
|
| Point Mutation | 1 | 2019 | 97 | 0.170 |
Why?
|
| Disease Progression | 1 | 2023 | 1038 | 0.170 |
Why?
|
| Dermatology | 1 | 2020 | 75 | 0.160 |
Why?
|
| Sleep | 1 | 2021 | 263 | 0.160 |
Why?
|
| Pain | 1 | 2021 | 472 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1553 | 0.140 |
Why?
|
| Mentha | 1 | 2015 | 4 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 2279 | 0.130 |
Why?
|
| Back | 1 | 2014 | 6 | 0.120 |
Why?
|
| Buttocks | 1 | 2014 | 16 | 0.120 |
Why?
|
| Borrelia burgdorferi | 1 | 2014 | 11 | 0.120 |
Why?
|
| Thigh | 1 | 2014 | 27 | 0.120 |
Why?
|
| Crohn Disease | 1 | 2014 | 38 | 0.120 |
Why?
|
| Doxycycline | 1 | 2014 | 49 | 0.120 |
Why?
|
| Antibodies, Bacterial | 1 | 2014 | 90 | 0.110 |
Why?
|
| Immunoglobulin M | 1 | 2014 | 172 | 0.110 |
Why?
|
| Treatment Outcome | 2 | 2021 | 7029 | 0.100 |
Why?
|
| Adolescent | 2 | 2015 | 8912 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 481 | 0.100 |
Why?
|
| Male | 4 | 2021 | 37321 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 1026 | 0.070 |
Why?
|
| Genotype | 1 | 2009 | 786 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 627 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 2077 | 0.060 |
Why?
|
| Low-Level Light Therapy | 1 | 2021 | 4 | 0.050 |
Why?
|
| Timolol | 1 | 2021 | 10 | 0.050 |
Why?
|
| Bandages | 1 | 2021 | 33 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2021 | 189 | 0.040 |
Why?
|
| Cheek | 1 | 2019 | 11 | 0.040 |
Why?
|
| Injections, Intralesional | 1 | 2019 | 25 | 0.040 |
Why?
|
| Watchful Waiting | 1 | 2019 | 25 | 0.040 |
Why?
|
| Remission Induction | 1 | 2019 | 111 | 0.040 |
Why?
|
| Wound Healing | 1 | 2021 | 260 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 951 | 0.040 |
Why?
|
| Registries | 1 | 2021 | 733 | 0.040 |
Why?
|
| Age Factors | 1 | 2021 | 1864 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 2093 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 3187 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2800 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 4655 | 0.020 |
Why?
|